The National Health Service has begun rolling out an innovative intravenous therapy that reduces administration time for 14 cancer types from the traditional two‑hour infusion to just 60 seconds. The rapid‑delivery jab, developed in partnership with leading pharmaceutical firms, streamlines drug preparation and eliminates the lengthy waiting periods that have long burdened patients and clinic staff. Early trials report improved patient comfort, increased throughput in oncology wards, and a notable boost in treatment adherence. Health officials anticipate that the new protocol will free up valuable pharmacy resources and allow more patients to receive timely care across the NHS network.
[EXACT_LINK: 🔗 Read More]